Key Highlights
- LITE achieved a record peak of $808.80 Thursday, settling at $777.17 by market close
- Recent inclusion in the S&P 500 triggered substantial index fund and ETF purchases
- Wall Street analysts elevated price targets, with increases reaching 66% in some cases
- Q2 results exceeded expectations — delivering EPS of $1.67 against $1.41 forecasts — while revenue surged 65.5% annually
- Company revealed plans for a 240,000 sq ft North Carolina production facility manufacturing lasers for AI infrastructure, counting Nvidia among its clientele
Lumentum (LITE) shares climbed to an unprecedented $808.80 peak Thursday before moderating to $777.17 at closing bell. During premarket trading on March 26, shares declined 3.49% to $750.
The stock’s remarkable ascent stems from a convergence of factors: bullish analyst sentiment, S&P 500 membership, exceptional quarterly performance, and a significant production capacity expansion.
The optical components manufacturer unveiled intentions to establish a laser production complex in Greensboro, North Carolina. The 240,000 square foot property, purchased from semiconductor manufacturer Qorvo (QRVO), will manufacture InP-based optical solutions, encompassing continuous wave and ultra-high-power laser systems.
Nvidia (NVDA) has been confirmed as a key client for the facility’s output. Manufacturing operations are projected to commence at full capacity by mid-2028.
The company anticipates investing several hundred million dollars at the location throughout the coming years. Management pledges to maintain and generate more than 400 domestic manufacturing positions.
CEO Michael Hurlston stated: “Our customers are building the infrastructure that will define the next era of computing. Adding this new InP manufacturing facility significantly expands our capacity, deepens our strategic partnerships, and ensures we can deliver the performance, reliability, and scale required for the AI revolution.”
Wall Street Price Target Revisions and Index Addition
A surge of bullish analyst revisions contributed momentum to LITE’s record performance. B. Riley upgraded shares from neutral to buy while dramatically increasing its price objective from $147 to $526. JPMorgan established a $565 target with an overweight stance. Citigroup moved to $560 with a buy recommendation. UBS lifted its forecast from $215 to $455 while maintaining a neutral position. Morgan Stanley increased its target to $595 but retained an equal weight designation.
The consensus analyst price target currently stands at $575.06, featuring two strong buy recommendations, eleven buy ratings, and six hold assessments.
Lumentum recently joined the S&P 500 index, a development that traditionally generates systematic buying pressure from passive investment vehicles. This structural demand likely amplified the stock’s upward trajectory.
Strong Quarterly Results Despite Valuation Concerns
During its latest reporting period, Lumentum delivered EPS of $1.67, surpassing the $1.41 consensus projection. Revenue totaled $665.50 million, representing a 65.5% year-over-year increase and exceeding the $646.74 million estimate. Management provided Q3 2026 EPS guidance ranging from $2.15 to $2.35.
However, some metrics warrant caution. The stock currently trades at a P/E ratio of 238, representing a significant premium by conventional standards. Corporate insiders have engaged in selling activity — CFO Wajid Ali divested 5,302 shares in late February at approximately $691.13 per share, while insiders collectively sold 65,775 shares during the past 90 days.
Institutional ownership comprises 94.05% of outstanding shares. Major holders including Vanguard, Arrowstreet Capital, and Geode Capital have expanded their stakes in recent periods.
Technical indicators show the 50-day moving average positioned at $567.66, while the 200-day average sits at $363.11 — both substantially below present price levels.





